Comments on Article by Tran and Associates, "Double-Blind Comparison of Olanzapine Versus Risperidone in Treatment of Schizophrenia and Other Psychotic Disorders"

Journal of Clinical Psychopharmacology

Volumn 18, Issue 2, 1998, Pages 176-177

  Gheuens, Jan ^a   Grebb, Jack A ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; NEUROLEPTIC AGENT; OLANZAPINE; PIRENZEPINE; RISPERIDONE;

HUMAN; LETTER; PSYCHOSIS; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; HUMANS; PIRENZEPINE; PSYCHOTIC DISORDERS; RISPERIDONE; SCHIZOPHRENIA;

EID: 0032040360     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/00004714-199804000-00015     Document Type: Letter

References (2)

1. Tran PV, Hamilton SH, Kuntz AJ, Potvin JH, Andersen SW, Beasley C, Tollefson GD. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol 1997;17:407-18.
2. Schooler NR. New antipsychotic medications: strategies for evaluation and selected findings. Schizophr Res 1997;27:249-260.